Objective-To define the ability of analysis of the signal averaged P wave to identify patients with paroxysmal atrial fibrillation (AF) and establish whether differences in quantitative variables between patients and controls are due to concurrent cardiopulmonary disease, greater atrial dimension, or to unrelated changes in atrial electrophysiology. Design 16-5 (14-1-21-2) v 14-5 (11-7-18-1) mV/s, P = 0*02; group B: 18-9 (14.8-21.8) v 14-3 (12-6-17.6) mV/s, P = 0.01). Energy contained in frequency bands from 20, 30, 40, 60 and 80 to 150 Hz was expressed as absolute values (P20, P30, P40, P60, and P80) and percentage energy ratios. P30, P60, and P80 were significantly greater in patients with AF in group A (for example P60: 3 9 (3.0-5'3) v 3-1 (2.0-4-3) pV2.s, P = 0.02) and P20, P30, and P40 were increased in those with AF in group B (for example P40: 16-7 (9.9-20.8) v 10-8 (8X1-14-8) ,iV2.s, P = 0.02). A score developed from logistic regression analysis of duration and P60 identified patients with paroxysmal AF with a sensitivity of 81% and specificity of 73%. Conclusions-Increased P wave duration and magnitude are associated with paroxysmal AF with and without additional cardiopulmonary disease. The discriminant ability of the signal averaged P wave is improved by analysis of duration and a magnitude variable. These results invite prospective assessment of the ability of the signal averaged P wave to predict paroxysmal AF in unselected patients. (Br Heart3J 1995;74:413-418) 
Main outcome measures-Analysis of the P wave after P-wave-specific signal averaging. Filtered P wave duration and spatial velocity were calculated. Energies contained in frequency bands from 20, 30, 40, 60, and 80 to 150 Hz after spectral analysis were expressed as absolute values (P20, P30 etc) and ratios of high to low frequency energy (PR20, PR30, etc) . Results-Duration and peak spatial velocity were increased in patients with paroxysmal AF (median (interquartile range) duration group A: 144 (137-155) v 136 (129-143) ms, P = 0 007; group B: 155 (144-159) v 142 (136-151) ms, P = 0-002; peak spatial velocity group A:
16-5 (14-1-21-2) v 14-5 (11-7-18-1) mV/s, P = 0*02; group B: 18-9 (14.8-21.8) v 14-3 (12-6-17.6) mV/s, P = 0.01). Energy contained in frequency bands from 20, 30, 40, 60 and 80 to 150 Hz was expressed as absolute values (P20, P30, P40, P60, and P80) and percentage energy ratios. P30, P60, and P80 were significantly greater in patients with AF in group A (for example P60: 3 9 (3.0-5'3) v 3-1 (2.0-4-3) pV2.s, P = 0.02) and P20, P30, and P40 were increased in those with AF in group B (for example P40: (9.9-20.8) v 10-8 (8X1-14-8) ,iV2.s, P = 0.02). A score developed from logistic regression analysis of duration and P60 identified patients with paroxysmal AF with a sensitivity of 81% and specificity of 73%. Conclusions-Increased P wave duration and magnitude are associated with paroxysmal AF with and without additional cardiopulmonary disease. The discriminant ability of the signal averaged P wave is improved by analysis of duration and a magnitude variable. These results invite prospective assessment of the ability of the signal averaged P wave to predict paroxysmal AF in unselected patients. ( Our methodology for selective P wave averaging has been described previously."1 Importantly, this technique ensures that only P waves with the same shape as the participant's most frequently occurring P wave are averaged.
A vector magnitude plot of the P wave was generated after averaging and the P wave limits defined automatically by the computer as we have reported," except that the frequency cut off of the filter we used for the current analysis was 40 Hz and the P wave end was defined as the point where the vector magnitude exceeded the minimum PR segment voltage by three standard deviations of the mean baseline value. P wave duration and root mean square (RMS) voltage were calculated between these limits. Because of interest in the possible existence of low amplitude terminal P wave signals ("atrial late potentials") in patients with paroxysmal AF,"2 we also determined the RMS voltage of the terminal 10, 20, and 30 ms of the P wave (RMS10, RMS20, RMS30).
Spatial velocity is the rate of change of voltage within the P wave signal in each orthogonal lead. It is a measure of the higher frequency magnitude of the P wave and the rapidity of directional change of the P wave vector during atrial activation. Spatial velocity was calculated by digitally differentiating the signal from each lead and then combining the three leads to produce a vector magnitude plot. The mean, peak, and ratio of peak to mean spatial velocity were calculated.
Spectral analysis was performed on the entire P wave as we have previously described." For the analysis presented in this paper we filtered signals with a high pass of 15 Hz before Fourier transformation to attenuate large low frequency components. P wave energy was estimated by summating the energies contained in frequency bands extending from 20, 30, 40, 60, and 80 to 150 Hz. We expressed these as absolute values (P20, P30, P40, P60, and P80) and percentage energy ratios (PR20, PR30, PR40, PR60, and PR80). For example, if P30 was the summation of the energies contained in frequency bands between 30 and 150 Hz, PR30 was the ratio of P30 to the summation of energies contained in frequency bands between 10 and 30 Hz multiplied by 100.
STATISTICAL METHODS
As the data were not all normally distributed results are expressed as median (interquartile range) except left atrial size (mean (SEM)).
Comparisons between patients and controls within groups A and B were performed using the Mann-Whitney U test for independent samples. Comparisons across all four groups were made with the Kruskal-Wallis test.'3 For both tests P < 0Q05 (two tailed) was considered significant. Where significant differences were found between groups the 95% confidence intervals for these differences are given. Correlation coefficients between left atrial diameter and various P wave variables were sought by Spearman rank test.
A multivariate analysis of the factors associated with the occurrence of paroxysmal AF was conducted using logistic regression.'4 The computer package BMDP'5 was used to find estimates and their standard errors. The logistic regression equation was used to develop a score to help identify patients who were likely to have paroxysmal AF. The discriminant ability of this score and univariate parameters derived from the P wave were explored using receiver operator curves in which the sensitivity (percentage of patients with paroxysmal AF correctly classified) was plotted against the specificity (percentage of controls correctly identified) for a range of cut off values.
As testing a scoring system on the data from which it was derived can lead to an over optimistic assessment of its diagnostic ability cross validation was used to obtain a more reliable estimate. In this approach each participant in turn is excluded during the fitting process and his or her paroxysmal AF status predicted. Prediction error rates can be then calculated. Table 1 gives details of each group. Table 2 summarises the cardiopulmonary conditions between left atrial size and P wave duration (r = 0 4, P < 0 05), mean spatial velocity (r = 0 3, P < 0-05), and lower frequency energy (P20, P30, and P40: all r = 0 3, P < 0-05) in controls.
Results

PATIENT GROUPS
UNIVARIATE DISCRIMINATION
Receiver operator curves were constructed for P wave duration, peak spatial velocity, ratio of peak to mean spatial velocity, P30, and P60 in all patients, group A, and group B. The cut off value selected for each variable was that which produced approximately equal values for specificity and sensitivity (table 5) . In all participants each of the variables assessed discriminated between patients and controls with sensitivities of 64-71% and Figure 3 Receiver operator plots for P wave duration alone (-----) and for P wave duration and P60 considered together using logistic regression (
).
Increased deviation of the latter curve to the top left of the graph implies increased discriminant ability. significant, improvement in the fit of the The increased P wave duration and magnimodel. Addition of further variables did not tude that we observed in patients with paroximprove performance of the formula. As fre-ysmal AF cannot be due to coexistent quency domain estimates of P wave energy cardiopulmonary disease or greater atrial size, gave better univariate discrimination than as patients and controls had a similar cardiac time domain measurement of RMS voltage or respiratory disease and comparable left duration and P60 were used to predict parox-atrial diameters. Moreover, we found only ysmal atrial fibrillation according to the for-moderate correlations between signal avermula:
aged P wave variables and left atrial diameter lnjp/(l-p)j = -13*42 (3 18) + 0 082 (0*02) in controls, and none in patients with paroxy-
smal AF or when all participants were examined. Some effect of atrial pathology was where duration and P60 are significant at observed on P wave duration (greater in con-P < 0-01 and values in brackets denote the trol patients with cardiac or pulmonary disstandard error of each coefficient.
ease than in normal controls) that would Table 5 and fig 3 show the sensitivities and cause an exaggeration of the difference in P specificities for this regression formula when wave duration if we had compared patients applied to all participants, group A, and group with paroxysmal AF and cardiopulmonary B. Important improvements over individual disease to normal controls-that is 155 v variables are evident with this combination. 136 ms. Thus, when P wave duration is Overall sensitivity improved to 76% and assessed it is important to ensure that patient specificity to 68% using a cut off score of and control groups are matched for the preva-45%. In group B the sensitivity was 81% with lence of additional cardiac disease. In most a specificity of 73% using a cut off score of of the published studies$9 12 of the signal 50%.
averaged P wave in paroxysmal AF differences Cross validation was performed for all in P wave duration may have been over patients and in groups A or B separately for a estimated by analysis of inadequately matched cut off score of 50%. In all patients a sensitiv-patient and control groups. ity of 69% with a specificity of 75% and an Use of quantitative variables derived from overall diagnostic accuracy (percentage of the signal averaged P wave identified patients individuals correctly diagnosed) of 72% was with paroxysmal AF with reasonable accuracy achieved. In group B the sensitivity was 65% if duration and a measure of P wave magniwith a specificity of 85% and a diagnostic tude were used together. The concerning the future usefulness of the P wave in arrhythmia diagnosis and prediction must await prospective studies in these patients.
In conclusion, quantitative analysis of the signal averaged P wave in patients with paroxysmal AF showed significant increases in P wave duration and magnitude that were related to the presence or absence of the arrhythmia rather than of concurrent cardiac or respiratory disease. Little relation was found between P wave variables and left atrial diameter. A score derived from these variables using a multivariate approach identified patients with paroxysmal AF with a sensitivity of 76% and specificity of 68% and therefore may be of some use as a diagnostic aid. Further assessment of the clinical utility of the signal averaged P wave for the diagnosis or prediction of paroxysmal AF requires investigation by prospective studies.
